Common use of Medical Inquiries for the Product Clause in Contracts

Medical Inquiries for the Product. Following the Effective Date, Pfizer, as the holder of the Product Approval, shall be responsible for handling all medical questions or inquiries in each such country in the Territory, including all Product Complaints, with regard to any Product sold by or on behalf of Pfizer (or any of its Affiliates or sublicensees) (including setting up a call center in connection therewith), in each case in accordance with applicable Law and this Agreement. Pfizer shall submit a copy of any standardized responses to medical inquiries prior to use thereof for Auxilium’s review and comment. Auxilium shall immediately forward any and all medical questions or inquiries which it receives with respect to any Product sold by or on behalf of Pfizer (or any of its Affiliates or sublicensees) in the Territory to Pfizer in accordance with all applicable Laws and Pfizer shall immediately forward to Auxilium any and all medical questions or inquiries that it receives with respect to Product (i) not sold by or on behalf of Pfizer (or any of its Affiliates or sublicensees) in the Territory or (ii) outside of the Territory, in each case in accordance with all applicable Laws. Notwithstanding the foregoing, Auxilium shall be primarily responsible for handling any Product Complaints related to the Manufacture of the Product, and Pfizer shall refer all such Product Complaints to Auxilium. ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

Medical Inquiries for the Product. Following the Effective Date, PfizerLicensee, as the holder intended beneficiary under this Agreement of the Product Approvalprivileges of ownership of the Regulatory Approvals in the Field in the Territory, shall be responsible for handling all medical questions or inquiries in each such country in the Territory, including all Product Complaints, with regard to any Product sold by or on behalf of Pfizer Licensee (or any of its Affiliates or sublicensees) (including setting up a call center in connection therewithAffiliates), in each case in accordance with applicable Law Applicable Laws and this Agreement. Pfizer VBL shall submit provide a copy of any standardized responses to medical inquiries prior to Licensee for Licensee’s use thereof for Auxilium’s review and commentwith respect to the Product in the Field in the Territory. Auxilium VBL shall immediately forward any and all medical questions or inquiries which it receives with respect to any Product sold by or on behalf of Pfizer Licensee (or any of its Affiliates or sublicenseesAffiliates) in the Territory to Pfizer Licensee in accordance with all applicable Applicable Laws and Pfizer Licensee shall immediately forward to Auxilium VBL any and all medical questions or inquiries that it receives with respect to Product (i) not sold by or on behalf of Pfizer Licensee (or any of its Affiliates or sublicenseesAffiliates) in the Territory or (ii) outside of the Territory, in each case in accordance with all applicable Applicable Laws. Notwithstanding the foregoing, Auxilium VBL shall be primarily responsible for handling any all Product Complaints other than those related to the Manufacture Development and Commercialization of the ProductProduct in the Field in the Territory, and Pfizer Licensee shall refer all such Product Complaints to AuxiliumVBL. ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUESTLicensee shall be responsible for handling all Product Complaints related to the Development and Commercialization of the Product in the Field in the Territory, and VBL shall refer all such Product Complaints to Licensee.

Medical Inquiries for the Product. Following the Effective Date, PfizerActelion, as the holder of the Product Approval, shall be responsible for handling all medical questions or inquiries in each such country in the Territory, including all Product Complaints, with regard to any Finished Product sold by or on behalf of Pfizer Actelion (or any of its Affiliates or sublicensees) (including setting up having a call center in connection therewith), in each case in accordance with applicable Law Laws and this Agreement. Pfizer Actelion shall submit a copy of any standardized responses to medical inquiries prior to use thereof for Auxilium’s review and comment. Auxilium shall immediately forward any and all medical questions or inquiries which it receives with respect to any Finished Product sold by or on behalf of Pfizer Actelion (or any of its Affiliates or sublicensees) in the Territory to Pfizer Actelion in accordance with all applicable Laws and Pfizer Actelion shall immediately forward to Auxilium any and all medical questions or inquiries that it receives with respect to Finished Product (i) not sold by or on behalf of Pfizer Actelion (or any of its Affiliates or sublicensees) in the Territory or (ii) outside of the Territory, in each case in accordance with all applicable Laws. Notwithstanding the foregoing, Auxilium shall be primarily responsible for handling any Product Complaints related to the Manufacture of the ProductManufacturing, and Pfizer Actelion shall refer all such Product Complaints to Auxilium. ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

Medical Inquiries for the Product. Following the Effective Date, Pfizer, as the holder of the Product Approval, Sobi shall be responsible for handling all medical questions or inquiries in each such country in the Territory, including all Product Complaints, with regard to any Finished Product sold by or on behalf of Pfizer Sobi (or any of its Affiliates or sublicensees) (including setting up having a call center in connection therewith), in each case in accordance with applicable Law Laws and this Agreement. Pfizer Auxilium shall provide a copy of its standardized responses to medical inquires for the Product. Sobi shall submit a copy of any standardized responses to medical inquiries prior to use thereof for Auxilium’s review and comment. Auxilium shall immediately forward any and all medical questions or inquiries which it receives with respect to any Finished Product sold by or on behalf of Pfizer Sobi (or any of its Affiliates or sublicensees) in the Territory to Pfizer Sobi in accordance with all applicable Laws and Pfizer Sobi shall immediately forward to Auxilium any and all medical questions or inquiries that it receives with respect to Finished Product (i) to Sobi’s knowledge not sold by or on behalf of Pfizer Sobi (or any of its Affiliates or sublicensees) in the Territory or (ii) outside of the Territory, in each case in accordance with all applicable Laws. Notwithstanding the foregoing, Auxilium shall be primarily responsible for handling any Product Complaints related to the Manufacture of the ProductManufacturing, and Pfizer Sobi shall refer all such Product Complaints to Auxilium. ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.